RMIT University researchers have described the promising cardioprotective effects of an Australian olive leaf extract at the American Heart Association?s 7th Annual Conference in Denver, USA.
Indu Singh, who led the RMIT research team, said the olive extract reduced blood platelet aggregation in laboratory investigations.
?Polyphenols from this olive leaf extract significantly inhibited platelet aggregation in the laboratory. This has important benefits as the antiplatelet effects in olive leaves may offer a degree of protection from thrombosis and other cardiovascular diseases,? said Ms Singh.
The findings, which have since been published in the medical journal, Nutrition, Metabolism & Cardiovascular Diseases, are yet another positive result for these unique liquid olive leaf extracts, which are made from fresh olive leaves, for maintaining cardiovascular health and normal heart function.
The new findings follow Australian and European research linking the polyphenols in olive leaves to lowered blood pressure and antibacterial, anti-inflammatory and antioxidant effects.
Olive Leaf Australia?s Corporate Development Director, Julian Archer, said he was excited about the results generated by one of his company?s products.
?We receive many reports from customers whose doctors are very happy with the cardiovascular and heart health benefits their patients are receiving from using the product,? said Mr Archer.
?It is very encouraging to see scientific studies supporting this and we expect results from further comprehensive clinical trials in the near future.?